Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,851 across all filing types
Latest filing 2023-03-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2022年度商誉减值测试报告
Audit Report / Information Classification · 95% confidence The document is titled '盈康生命科技股份有限公司商誉减值测试报告' which translates to 'Goodwill Impairment Test Report of Yingkang Life Technology Co., Ltd.' It is a detailed report on goodwill impairment testing for the fiscal year 2022, including asset group evaluations, impairment indicators, assumptions, calculation of impairment losses, and related financial data. The content is focused on impairment testing and valuation rather than a full annual report or earnings release. It is not a brief announcement or a certification letter but a substantive standalone report on goodwill impairment. Therefore, it fits the category of an Audit Report / Information (AR), which includes applied accounting principles and results of internal or regulatory stress tests, such as impairment testing reports. FY 2022
2023-03-29 Chinese
安信证券股份有限公司关于盈康生命科技股份有限公司2022年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as a verification opinion from a sponsoring institution (安信证券股份有限公司) on the 2022 internal control self-evaluation report of 盈康生命科技股份有限公司. It discusses the internal control evaluation, governance structure, risk assessment, control activities, and internal audit related to the company. The document is a detailed review and opinion on the internal control report rather than the report itself. It does not contain financial statements or quarterly/yearly financial results but focuses on internal control compliance and effectiveness. This type of document aligns with an Audit Report / Information (AR) category, which includes standalone audit reports and internal control evaluations. The document length is 5867 characters, sufficient for a substantive report rather than a brief announcement. Therefore, the classification is AR with high confidence. FY 2022
2023-03-29 Chinese
关于举行2022年度报告网上业绩说明会的公告
AGM Information Classification · 90% confidence The document is an announcement about holding an online performance explanation meeting related to the 2022 Annual Report. It states the date and time of the meeting and invites investors to participate and submit questions. The document does not contain the actual annual report or financial data but rather informs about the upcoming event to discuss the report. The document length is short (865 characters), and it serves as a notice rather than the report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement or related event announcement, not the annual report itself. Therefore, the appropriate classification is AGM Information (AGM-R) since it is about an annual report performance explanation meeting, which is a type of AGM-related presentation material.
2023-03-24 Chinese
第五届董事会第三十次(临时)会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the company's fifth board of directors' 30th (extraordinary) meeting. It details the meeting's convening, attendance, agenda, and voting results, specifically regarding an investment fund and related party transactions. There is no financial data, earnings information, or report publication mentioned. The content focuses on board decisions and approvals, which aligns with announcements about board or management information. The document length is short (1691 characters), and it is not a report or a notice of report publication. Therefore, the appropriate classification is Board/Management Information (MANG).
2023-02-10 Chinese
独立董事关于第五届董事会第三十次(临时)会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal statement from independent directors providing prior approval opinions on a specific board meeting matter related to joint investment and related party transactions. It references company governance rules and regulatory guidelines but does not contain financial statements, earnings data, or detailed report content. The document is short (637 characters) and serves as a governance or board-related announcement rather than a full report or financial disclosure. It fits best under Board/Management Information (MANG) as it concerns board-level approvals and governance matters.
2023-02-10 Chinese
第五届监事会第二十八次(临时)会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding a specific meeting held on February 10, 2023. It details the meeting's convening, attendance, and the approval of a related-party transaction involving professional investment institutions. The document is an official announcement of a board/management decision rather than a full report or financial statement. It does not contain financial data or detailed financial analysis, nor is it a shareholder meeting material or voting result announcement. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management bodies.
2023-02-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.